查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全基因组测序市场规模、份额和趋势分析报告，按产品（仪器、耗材、服务）、类型、工作流程、应用、最终用途、地区、细分市场预测，2023-2030 年
市场调查报告书
商品编码
1233234

全基因组测序市场规模、份额和趋势分析报告，按产品（仪器、耗材、服务）、类型、工作流程、应用、最终用途、地区、细分市场预测，2023-2030 年

Whole Genome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Type, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

全基因组测序市场增长和趋势

Grand View Research, Inc. 的一份新报告显示，从 2023 年到 2030 年，全球全基因组测序市场规模将以 20.06% 的复合年增长率增长，到 2030 年将达到 66.7 亿美元。

这一市场增长的推动因素是全基因组测序在基因组作图计划中的日益普及以及遗传病（包括罕见遗传病）患病率的上升。您可以 2021 年 11 月发表在《新英格兰医学杂誌》上的一项研究报告称，全基因组测序将使多种罕见疾病的早期诊断成为可能，从而导致向精准医学的转变。

此外，增加对使用 WGS 早期检测和治疗疾病的研发投资也有望推动市场增长。 例如，2023 年 2 月，印度尼西亚政府和基因组科学计划从全球基金获得了 3000 万美元的投资，用于早期检测和诊断 COVID-19、结核病、癌症、遗传病、脑部疾病等疾病, 代谢紊乱. 建立了实施治疗方法的设施网络。

全基因组测序具有广泛的应用，随着政府机构采用这些技术解码人类、植物、动物和微生物基因组，预计将推动市场增长。我来了。 例如，美国食品和药物管理局（FDA）在各国食源性疾病暴发期间就采用这种方法来鑑定食源性病原体。 自 2008 年以来，FDA 在其全基因组测序 (WGS) 计划下采用了这项技术，因为它可以比脉衝场凝胶电泳 (PFGE) 更有效地识别所有食源性病原体菌株。

随着技术的进步，创新的全基因组测序产品相继推出，可为各种疾病和感染提供经济实惠、准确且及时的诊断。 这有助于市场增长。 例如，2022 年 12 月，LifeCell International Pvt. Ltd. 与 Haystack Analytics 合作推出了全基因组测序测试“TB”，以确定结核病感染的诊断信息并应对耐药性挑战。

COVID-19 大流行增加了全球对该技术的需求，从而能够快速识别 SARS-CoV-2 并开发可能的诊断测试来控制疫情。 因此，世界各国政府与研究机构和公司合作，使用这种方法来识别和诊断 SARS-CoV-2。 几家公司已经宣布了用于监测 SARS-CoV-2 病毒的基因组服务和快速解决方案。 例如，QIAGEN 提供全基因组测序服务 SARS-CoV-2 监测，用于识别强效变异体、追踪可能的爆发以及推进疫苗研究和药物开发。

全基因组测序市场报告亮点

  • 消耗品部分在 2022 年占据了最大份额，达到 61.56%，这是因为可用的消耗品种类繁多，而且由于这些产品的使用时间较短，因此采用率越来越高。。
  • 按类型划分，大型全基因组测序细分市场在 2022 年全基因组测序市场中所占份额最大，为 77.32%。 这可能是由于癌症肿瘤分析和罕见疾病基因突变鑑定等应用的扩展。
  • 按工作流程划分，测序部分在 2022 年占据了 52.12% 的最大市场份额，这是由于大公司越来越多地参与以及新产品的推出推动了该流程的采用。
  • 按应用划分，人类全基因组测序细分市场在 2022 年以 62.91% 的份额占据市场主导地位。 这可能是由于罕见遗传病的流行率不断上升，以及为查明这些疾病的病原体而进行的研发投资不断增加。
  • 按最终用途划分，学术和研究部门以 48.72% 的最大份额主导着全球市场。 该细分市场的很大一部分归因于这些设施对高通量技术的需求不断增长，以便在该领域进行综合研究。
  • 北美在 2022 年所占份额最大，为 51.34%。 这一巨大份额可归因于该地区成熟的医疗保健系统和製药业的存在，从而对用于临床和研究目的的全基因组测序产生了巨大需求。

内容

第一章调查方法及范围

  • 信息采购
  • 信息或数据分析
  • 市场范围和细分定义
  • 市场模型
    • 市场调查，按公司市场份额
    • 区域分析

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第 3 章市场变量、趋势和范围

  • 市场细分和范围
  • 市场系列展望
    • 母公司市场展望
    • 相关/子公司市场前景
  • 市场动态
    • 遗传病患病率上升
    • 降低基因测序的成本
    • 基因组作图项目对全基因组测序的需求不断增长
  • 市场製约因素分析
    • 与基因组测序相关的伦理和法律问题
  • 行业分析工具
    • 波特的五力分析
    • 宏观经济分析
  • COVID-19 影响分析

第 4 章全基因组测序市场：产品业务分析

  • 全基因组测序市场：产品市场份额分析
  • 全基因组测序市场的估计和预测，按产品分类（百万美元）
  • 设备
  • 消耗品
  • 服务

第 5 章全基因组测序市场：类型业务分析

  • 全基因组测序市场：类型市场份额分析
  • 全基因组测序市场按类型估算和预测（百万美元）
  • 大规模全基因组测序
  • 小型全基因组测序

第 6 章全基因组测序市场：工作流程业务分析

  • 全基因组测序市场：工作流程市场份额分析
  • 按工作流程估算和预测全基因组测序市场（百万美元）
  • 前序
  • 测序
  • 数据分析

第 7 章全基因组测序市场：应用业务分析

  • 全基因组测序市场：应用市场份额分析
  • 全基因组测序市场按应用估算和预测（百万美元）
  • 人类全基因组测序
  • 全植物外显子组测序
  • 全动物外显子组测序
  • 微生物全外显子组测序

第 8 章全基因组测序市场：最终用途业务分析

  • 全基因组测序市场：最终用途市场份额分析
  • 全基因组测序市场的估计和预测，按最终用途（百万美元）
  • 学术和研究机构
  • 医院和诊所
  • 製药和生物技术公司
  • 其他

第 9 章全基因组测序市场：区域业务分析

  • 2022 年和 2030 年各地区全基因组测序市场份额
  • 北美
    • 美国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 加拿大
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 欧洲
    • 德国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 英国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 法国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 意大利
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 西班牙
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 丹麦
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 瑞典
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 挪威
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 亚太地区
    • 日本
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 中国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 印度
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 韩国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 澳大利亚
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 泰国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 拉丁美洲
    • 巴西
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 墨西哥
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 阿根廷
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 多边环境协定
    • 南非
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 沙特阿拉伯
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 科威特
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景

第10章竞争格局

  • 公司分类
  • 2022 年市场公司份额分析
  • 战略规划
  • 公司简介/列表
    • Illumina, Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Thermo Fisher Scientific, Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Oxford Nanopore Technologies
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Pacific Biosciences of California, Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • BGI
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • QIAGEN
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Agilent Technologies
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • ProPhase Labs, Inc. (Nebula Genomics)
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Psomagen
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Azenta US, Inc. (GENEWIZ)
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
Product Code: GVR-4-68040-037-0

Whole Genome Sequencing Market Growth & Trends:

The global whole genome sequencing market size is projected to reach USD 6.67 billion by 2030, expanding at a CAGR of 20.06% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising adoption of whole genome sequencing for genome mapping programs and the increasing prevalence of inherited disorders, including rare genetic disorders. According to the study published in the New England Journal of Medicine in November 2021, whole genome sequencing could lead to the early diagnosis of a wide range of rare diseases and a reported transition to precision medicine.

Furthermore, the growing investment in R&D for the early detection and treatment of disorders with the aid of WGS is expected to propel the growth of the market. For instance, in February 2023, the government of Indonesia and the Genome Science Initiative, with the aid of a USD 30 million investment from the Global Fund, established a network of facilities to perform the method for the early detection and treatment of disorders, including COVID-19, tuberculosis, cancer, genetic disorders, brain diseases, and metabolic disorders.

Whole genome sequencing has a wide range of applications, and government bodies are adopting these technologies for sequencing the genomes of humans, plant, animal, and microbes, which is expected to drive market growth. For instance, U.S. Food & Drug Administration (FDA) adopted the method to identify foodborne pathogens during foodborne disease outbreaks across the countries. The FDA has adopted this technology since 2008 under the Whole Genome Sequencing (WGS) program as it enables it to distinguish all strains of foodborne pathogens more efficiently than pulse-field gel electrophoresis (PFGE).

The rising technological advancements have led to the launch of innovative whole genome sequencing products that offer an affordable, accurate, and timely diagnosis of various diseases and infections. This is contributing to the growth of the market. For instance, in December 2022, LifeCell International Pvt. Ltd. collaborated with HaystackAnalytics to launch TB, a whole genome sequencing test to identify the diagnostic information on tuberculosis infections and tackle the drug resistance challenge.

The COVID-19 pandemic led to an increased demand for the method globally, which enabled the rapid identification of SARS-CoV-2 and the development of possible diagnostic tests to manage the outbreak. Hence, governments across the globe collaborated with research organizations and the corporate sector to use the method to identify and diagnose SARS-CoV-2. Several companies have launched genomic services and rapid solutions for the surveillance of the SARS-CoV-2 virus. For instance, QIAGEN offers the whole genome sequencing services SARS-CoV-2 surveillance for the identification of potent mutants, tracing of possible outbreaks, and advancement of vaccine research and drug development.

Whole Genome Sequencing Market Report Highlights:

  • Consumables segment held the largest share of 61.56% in 2022, owing to the availability of a wide range of consumables and increased adoption of these products due to the shorter duration of use of these products
  • By type, the large whole genome sequencing segment accounted for the largest share of 77.32% in the whole genome sequencing market in 2022. This can be attributed to the growing applications for analyzing cancerous tumors and identifying genetic variations in rare diseases
  • By workflow, the sequencing segment held the largest market share of 52.12% in 2022, owing to the growing involvement of major companies and the launch of novel products to boost the adoption of the process
  • By application, the human whole genome sequencing segment dominated the market in 2022 with a share of 62.91%. This can be attributed to the growing prevalence of rare inherited disorders and growing investment in R&D for the method to identify possible causative agents of these disorders
  • By end-use, the academic & research institutes segment dominated the global market with the largest share of 48.72%. The large share of the segment can be attributed to the growing demand for high-throughput technologies at these facilities to conduct comprehensive research in this field
  • North America held the largest market share of 51.34% in 2022. The large share can be attributed to the presence of a well-established healthcare system and pharmaceutical industry in the region, which has created a significant demand for whole genome sequencing for clinical and research purposes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Rising prevalence of inherited disorders
    • 3.3.2. Decreasing costs for genetic sequencing
    • 3.3.3. Rising demand for whole genome sequencing for genome mapping programs
  • 3.4. Market Restraint Analysis
    • 3.4.1. Ethical and legal challenges associated with genomic sequencing
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. Macroeconomic Analysis
  • 3.6. COVID-19 Impact Analysis

Chapter 4. Whole Genome Sequencing Market: Product Business Analysis

  • 4.1. Whole Genome Sequencing Market: Product Market Share Analysis
  • 4.2. Whole Genome Sequencing Market Estimates & Forecast, By Product (USD Million)
  • 4.3. Instruments
    • 4.3.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Whole Genome Sequencing Market: Type Business Analysis

  • 5.1. Whole Genome Sequencing Market: Type Market Share Analysis
  • 5.2. Whole Genome Sequencing Market Estimates & Forecast, By Type (USD Million)
  • 5.3. Large Whole Genome Sequencing
    • 5.3.1. Large Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 5.4. Small Whole Genome Sequencing
    • 5.4.1. Small Whole Genome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 6. Whole Genome Sequencing Market: Workflow Business Analysis

  • 6.1. Whole Genome Sequencing Market: Workflow Market Share Analysis
  • 6.2. Whole Genome Sequencing Market Estimates & Forecast, By Workflow (USD Million)
  • 6.3. Pre-Sequencing
    • 6.3.1. Pre-Sequencing Market, 2018 - 2030 (USD Million)
  • 6.4. Sequencing
    • 6.4.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 6.5. Data Analysis
    • 6.5.1. Data Analysis Market, 2018 - 2030 (USD Million)

Chapter 7. Whole Genome Sequencing Market: Application Business Analysis

  • 7.1. Whole Genome Sequencing Market: Application Market Share Analysis
  • 7.2. Whole Genome Sequencing Market Estimates & Forecast, By Application (USD Million)
  • 7.3. Human Whole Genome Sequencing
    • 7.3.1. Human Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.4. Plant Whole Exome Sequencing
    • 7.4.1. Plant Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.5. Animal Whole Exome Sequencing
    • 7.5.1. Animal Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.6. Microbial Whole Exome Sequencing
    • 7.6.1. Microbial Market, 2018 - 2030 (USD Million)

Chapter 8. Whole Genome Sequencing Market: End-Use Business Analysis

  • 8.1. Whole Genome Sequencing Market: End-Use Market Share Analysis
  • 8.2. Whole Genome Sequencing Market Estimates & Forecast, By End-Use (USD Million)
  • 8.3. Academic & Research Institutes
    • 8.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 8.5. Pharmaceutical & Biotechnology Companies
    • 8.5.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Whole Genome Sequencing Market: Regional Business Analysis

  • 9.1. Whole Genome Sequencing Market Share By Region, 2022 & 2030
  • 9.2. North America
    • 9.2.1. North America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Target Disease Prevalence
      • 9.2.2.3. Competitive Scenario
      • 9.2.2.4. Regulatory Framework
      • 9.2.2.5. Reimbursement Scenario
      • 9.2.2.6. U.S. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. Canada Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.2. Germany
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. Germany Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.3. U.K.
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. U.K. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. France Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. Italy Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Spain Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Denmark Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Sweden Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Norway Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Japan Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. China Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. India Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. South Korea Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. Australia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Thailand Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Brazil Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Mexico Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. Argentina Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. South Africa Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Saudi Arabia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. UAE Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. Kuwait Whole Genome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Company Market Share Analysis, 2022
  • 10.3. Strategy Mapping
  • 10.4. Company Profiles/Listing
    • 10.4.1. Illumina, Inc.
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Thermo Fisher Scientific, Inc.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Oxford Nanopore Technologies
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Pacific Biosciences of California, Inc.
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. BGI
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. QIAGEN
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Agilent Technologies
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. ProPhase Labs, Inc. (Nebula Genomics)
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Psomagen
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Azenta US, Inc. (GENEWIZ)
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Global whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 Global whole genome sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 11 North America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 12 North America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 13 North America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 14 North America whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 U.S. whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 16 U.S. whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 17 U.S. whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 U.S. whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 19 U.S. whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Canada whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 21 Canada whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 22 Canada whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 23 Canada whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 24 Canada whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Europe whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 27 Europe whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 28 Europe whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 29 Europe whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 30 Europe whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 U.K. whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 32 U.K. whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 33 U.K. whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 34 U.K. whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 35 U.K. whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Germany whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 37 Germany whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 38 Germany whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 Germany whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 40 Germany whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 France whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 42 France whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 43 France whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 44 France whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 45 France whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Italy whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 47 Italy whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 48 Italy whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 49 Italy whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 50 Italy whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Spain whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 52 Spain whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 53 Spain whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 54 Spain whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Spain whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Denmark whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 57 Denmark whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 58 Denmark whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 59 Denmark whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 60 Denmark whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Sweden whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 62 Sweden whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 63 Sweden whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 64 Sweden whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 65 Sweden whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Norway whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Norway whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 68 Norway whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 69 Norway whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 70 Norway whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Japan whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 78 Japan whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 79 Japan whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 Japan whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 81 Japan whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 China whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 83 China whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 84 China whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 85 China whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 86 China whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 India whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 88 India whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 89 India whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 90 India whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 91 India whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Australia whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 93 Australia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 94 Australia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 95 Australia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 96 Australia whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 97 Thailand whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 98 Thailand whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 99 Thailand whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 100 Thailand whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 101 Thailand whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 102 South Korea whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 103 South Korea whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 104 South Korea whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 105 South Korea whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 106 South Korea whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 107 Latin America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 108 Latin America whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 109 Latin America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 110 Latin America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 111 Latin America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 112 Latin America whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 113 Brazil whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 114 Brazil whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 115 Brazil whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 116 Brazil whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 117 Brazil whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 118 Mexico whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 119 Mexico whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 120 Mexico whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 121 Mexico whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 122 Mexico whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 123 Argentina whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 124 Argentina whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 125 Argentina whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 126 Argentina whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 127 Argentina whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 134 South Africa whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 135 South Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 136 South Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 137 South Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 138 South Africa whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 144 UAE whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 145 UAE whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 146 UAE whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 147 UAE whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 148 UAE whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 150 Kuwait whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 152 Kuwait whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 154 Participant's overview
  • Table 155 Financial performance
  • Table 156 Key companies undergoing expansions
  • Table 157 Key companies undergoing acquisitions
  • Table 158 Key companies undergoing collaborations
  • Table 159 Key companies launching new products/services
  • Table 160 Key companies undergoing partnerships
  • Table 161 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Whole genome sequencing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Related/ancillary market outlook
  • Fig. 14 Whole genome sequencing - Industry value chain analysis
  • Fig. 15 Whole genome sequencing market dynamics
  • Fig. 16 Whole genome sequencing market: Porter's analysis
  • Fig. 17 Whole genome sequencing market: PESTLE analysis
  • Fig. 18 Whole genome sequencing market: Product outlook and key takeaways
  • Fig. 19 Whole genome sequencing market: Product market share analysis, 2022 - 2030
  • Fig. 20 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 21 Global consumables market, 2018 - 2030 (USD Million)
  • Fig. 22 Global services market, 2018 - 2030 (USD Million)
  • Fig. 23 Whole genome sequencing market: Type outlook and key takeaways
  • Fig. 24 Whole genome sequencing market: Type market share analysis, 2022 - 2030
  • Fig. 25 Global large whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 26 Global small whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 27 Whole genome sequencing market: Workflow outlook and key takeaways
  • Fig. 28 Whole genome sequencing market: Workflow market share analysis, 2022 - 2030
  • Fig. 29 Global pre-sequencing market, 2018 - 2030 (USD Million)
  • Fig. 30 Global sequencing market, 2018 - 2030 (USD Million)
  • Fig. 31 Global data analysis market, 2018 - 2030 (USD Million)
  • Fig. 32 Whole genome sequencing market: Application outlook and key takeaways
  • Fig. 33 Whole genome sequencing market: Application market share analysis, 2022 - 2030
  • Fig. 34 Global human whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 35 Global plant whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 36 Global animal whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 37 Global microbial whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 38 Whole genome sequencing market: End-use outlook and key takeaways
  • Fig. 39 Whole genome sequencing market: End-use market share analysis, 2022 - 2030
  • Fig. 40 Global academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 41 Global hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 42 Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 43 Global others market, 2018 - 2030 (USD Million)
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 Regional marketplace: Key takeaways
  • Fig. 46 North America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. key country dynamics
  • Fig. 48 U.S. whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Canada key country dynamics
  • Fig. 50 Canada whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 51 Europe whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 U.K. key country dynamics
  • Fig. 53 U.K. whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Germany key country dynamics
  • Fig. 55 Germany whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 France key country dynamics
  • Fig. 57 France whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Italy key country dynamics
  • Fig. 59 Italy whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Spain key country dynamics
  • Fig. 61 Spain whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark key country dynamics
  • Fig. 63 Denmark whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden key country dynamics
  • Fig. 65 Sweden whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Norway key country dynamics
  • Fig. 67 Norway whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Asia-Pacific whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Japan key country dynamics
  • Fig. 70 Japan whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 China key country dynamics
  • Fig. 72 China whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 India key country dynamics
  • Fig. 74 India whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Australia key country dynamics
  • Fig. 76 Australia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Thailand key country dynamics
  • Fig. 78 Thailand whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 South Korea key country dynamics
  • Fig. 80 South Korea whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Brazil key country dynamics
  • Fig. 83 Brazil whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Mexico key country dynamics
  • Fig. 85 Mexico whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Argentina key country dynamics
  • Fig. 87 Argentina whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 MEA whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 South Africa key country dynamics
  • Fig. 90 South Africa whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Saudi Arabia key country dynamics
  • Fig. 92 Saudi Arabia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 UAE key country dynamics
  • Fig. 94 UAE whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait key country dynamics
  • Fig. 96 Kuwait whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Key company categorization
  • Fig. 98 Company market positioning
  • Fig. 99 Company market share analysis, 2022
  • Fig. 100 Market participant categorization
  • Fig. 101 Strategy framework